195 related articles for article (PubMed ID: 24528687)
1. Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study.
Ito MK; Maki KC; Brinton EA; Cohen JD; Jacobson TA
J Clin Lipidol; 2014; 8(1):69-76. PubMed ID: 24528687
[TBL] [Abstract][Full Text] [Related]
2. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
[TBL] [Abstract][Full Text] [Related]
3. Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.
Cohen JD; Brinton EA; Ito MK; Jacobson TA
J Clin Lipidol; 2012; 6(3):208-15. PubMed ID: 22658145
[TBL] [Abstract][Full Text] [Related]
4. Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey.
Jacobson TA; Khan A; Maki KC; Brinton EA; Cohen JD
J Clin Lipidol; 2018; 12(1):78-88. PubMed ID: 29239815
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study.
Skarlovnik A; Janić M; Lunder M; Turk M; Šabovič M
Med Sci Monit; 2014 Nov; 20():2183-8. PubMed ID: 25375075
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome is associated with muscle symptoms among statin users.
Brinton EA; Maki KC; Jacobson TA; Sponseller CA; Cohen JD
J Clin Lipidol; 2016; 10(4):1022-1029. PubMed ID: 27578135
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced myopathy: a review and update.
Abd TT; Jacobson TA
Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
[TBL] [Abstract][Full Text] [Related]
8. [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].
Reiner Z; Galić M; Hanzevacki M; Tedeschi-Reiner E
Lijec Vjesn; 2005; 127(3-4):65-8. PubMed ID: 16193855
[TBL] [Abstract][Full Text] [Related]
9. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics.
Neuvonen PJ
Curr Opin Investig Drugs; 2010 Mar; 11(3):323-32. PubMed ID: 20178046
[TBL] [Abstract][Full Text] [Related]
10. Pitavastatin therapy in polymedicated patients is associated with a low risk of drug-drug interactions: analysis of real-world and phase 3 clinical trial data.
Gosho M; Tanahashi M; Hounslow N; Teramoto T
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):635-46. PubMed ID: 26104032
[TBL] [Abstract][Full Text] [Related]
11. The genetics of statin-induced myopathy.
Ghatak A; Faheem O; Thompson PD
Atherosclerosis; 2010 Jun; 210(2):337-43. PubMed ID: 20042189
[TBL] [Abstract][Full Text] [Related]
12. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
Shanahan RL; Kerzee JA; Sandhoff BG; Carroll NM; Merenich JA
Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281
[TBL] [Abstract][Full Text] [Related]
13. Changes in muscle strength in patients with statin myalgia.
Panza GA; Taylor BA; Roman W; Thompson PD
Am J Cardiol; 2014 Oct; 114(8):1215-6. PubMed ID: 25171803
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in 45 patients with statin-associated myopathy.
Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
[TBL] [Abstract][Full Text] [Related]
15. Muscle-related side-effects of statins: from mechanisms to evidence-based solutions.
Taylor BA; Thompson PD
Curr Opin Lipidol; 2015 Jun; 26(3):221-7. PubMed ID: 25943841
[TBL] [Abstract][Full Text] [Related]
16. Effect of thyroid hormone status and concomitant medication on statin induced adverse effects in hyperlipidemic patients.
Berta E; Harangi M; Zsíros N; Nagy EV; Paragh G; Bodor M
Pharmazie; 2014 Jun; 69(6):420-3. PubMed ID: 24974574
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6*4 polymorphism is associated with statin-induced muscle effects.
Frudakis TN; Thomas MJ; Ginjupalli SN; Handelin B; Gabriel R; Gomez HJ
Pharmacogenet Genomics; 2007 Sep; 17(9):695-707. PubMed ID: 17700359
[TBL] [Abstract][Full Text] [Related]
18. Flavonoid-statin interactions causing myopathy and the possible significance of OATP transport, CYP450 metabolism and mevalonate synthesis.
Zechner J; Britza SM; Farrington R; Byard RW; Musgrave IF
Life Sci; 2022 Feb; 291():119975. PubMed ID: 34560084
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study.
Karalis DG; Wild RA; Maki KC; Gaskins R; Jacobson TA; Sponseller CA; Cohen JD
J Clin Lipidol; 2016; 10(4):833-841. PubMed ID: 27578114
[TBL] [Abstract][Full Text] [Related]
20. Aerobic Exercise Performance and Muscle Strength in Statin Users-The LIFESTAT Study.
Morville T; Dohlmann TL; Kuhlman AB; Sahl RE; Kriegbaum M; Larsen S; Dela F; Helge JW
Med Sci Sports Exerc; 2019 Jul; 51(7):1429-1437. PubMed ID: 31210648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
